Report Categories
View AllRecent Articles
View All
Why AGI Inc AGBK could be the anchor your portfolio needs Jumps 20260507
Sol STKE shares surge despite wider losses as revenue growth accelerates 818 yearoveryear
SXI Standex International Corporation reports Q1 2026 EPS beat and 96 YoY revenue growth but shares drop 102
How Alphabet GOOGL earnings power stacks up historically Alphabet Posts 31 EPS Miss Amid Cost Pressure
MLCI Mount management unveils new strategic growth priorities focused on expanding alternative investment portfolios to boost longterm investor returns
What BRC Group RILYZ is doing to earn customer loyalty Stalls 20260508
The reasons Backblaze BLZE could be underpriced Smart Money Exits 20260506
Indias Satirical Cockroach Party Faces Website Blocking Raising Digital Freedom Concerns
Senco Gold Q4 Profit Surges 151 to Rs 157 Crore on Strong Gold Prices and Wedding Demand
Treasury Yield Surge Challenges RiskFree Notion Opening Opportunities in Intermediate and HighYield Bonds
Dow Jones Rises 276 Points on Jobless Claims Surprise and Quantum Computing Push Nvidia Slips but AI and Space Stocks Gain
Motley Fool Highlights Biotech Stock as Potential Healthcare Opportunity
Dating Startups Tackle Fake Profiles TrustFocused Services Gain Traction in Online Dating Industry
Cheche Group Q4 2024 Earnings EPS Beats Estimates as Loss Narrows but Shares Slide
DUOT Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction
ACRS Q1 2026 Earnings Narrower Net Loss Beats Expectations as Cost Management Continues
Cardinal Infrastructure Group Inc CDNL Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Disappointment
TIPT Q2 2025 Earnings Earnings Beat with No Consensus Estimate Stock Gains
TNMG Q4 2025 Earnings Massive EPS Miss and Stock Rally A Contradiction
Olenox Industries OLOX Holds Steady Near Support After Minimal Decline
Intercont NCT Rises 385 as Stock Approaches Key Resistance Level
EnerSys ENS Slides 314 as Selling Pressure Persists Key Support in Focus
Inseego Corp INSG Surges 322 as Shares Test Key Resistance Level
Prime Medicine PRME Surges Over 11 as Gene Editing Stock Finds Support Near 313